EMILY HARRIS: Open Payments
NPI 1801345244 · GLEN MILLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 13 payments from 8 companies in 2025. Trend: 2023 $285 · 2024 $543 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $58 |
| PFIZER INC. | 2 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| ABBVIE INC. | 2 | $35 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $27 |
| Olympus America Inc. | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
Products named: Auvelity, XELJANZ, XIFAXAN, PURIFIED CORTROPHIN GEL, TREMFYA, LINZESS, VISIGLIDE, ACTHAR.
Industry payments across PA — which companies pay providers there.
